BlackRock’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$93.6M Buy
5,848,285
+484,063
+9% +$7.75M ﹤0.01% 2069
2025
Q1
$91.7M Buy
5,364,222
+221,151
+4% +$3.78M ﹤0.01% 2024
2024
Q4
$127M Buy
5,143,071
+89,921
+2% +$2.23M ﹤0.01% 1924
2024
Q3
$144M Buy
5,053,150
+137,023
+3% +$3.91M ﹤0.01% 1845
2024
Q2
$130M Buy
4,916,127
+439,327
+10% +$11.6M ﹤0.01% 1867
2024
Q1
$145M Sell
4,476,800
-53,916
-1% -$1.74M ﹤0.01% 1826
2023
Q4
$191M Buy
4,530,716
+399,051
+10% +$16.8M ﹤0.01% 1661
2023
Q3
$159M Sell
4,131,665
-69,649
-2% -$2.67M ﹤0.01% 1681
2023
Q2
$79.7M Buy
4,201,314
+264,133
+7% +$5.01M ﹤0.01% 2170
2023
Q1
$61.1M Buy
3,937,181
+7,757
+0.2% +$120K ﹤0.01% 2281
2022
Q4
$69.7M Buy
3,929,424
+422,750
+12% +$7.5M ﹤0.01% 2222
2022
Q3
$19.6M Sell
3,506,674
-124,636
-3% -$695K ﹤0.01% 2995
2022
Q2
$14.2M Buy
3,631,310
+277,444
+8% +$1.08M ﹤0.01% 3229
2022
Q1
$18.5M Buy
3,353,866
+28,865
+0.9% +$159K ﹤0.01% 3148
2021
Q4
$28.3M Buy
3,325,001
+76,000
+2% +$647K ﹤0.01% 2995
2021
Q3
$28.2M Buy
3,249,001
+146,214
+5% +$1.27M ﹤0.01% 3008
2021
Q2
$32.8M Sell
3,102,787
-582,229
-16% -$6.15M ﹤0.01% 2944
2021
Q1
$59.1M Sell
3,685,016
-1,114,571
-23% -$17.9M ﹤0.01% 2480
2020
Q4
$222M Buy
4,799,587
+1,270,446
+36% +$58.7M 0.01% 1529
2020
Q3
$124M Buy
3,529,141
+1,226,550
+53% +$43.2M ﹤0.01% 1728
2020
Q2
$56.1M Buy
2,302,591
+1,399,624
+155% +$34.1M ﹤0.01% 2160
2020
Q1
$14.1M Buy
902,967
+303,100
+51% +$4.72M ﹤0.01% 2759
2019
Q4
$9.52M Buy
+599,867
New +$9.52M ﹤0.01% 3230